Product/Composition:- | Letrozole |
---|---|
Strength:- | 2.5 mg |
Form:- | Tablets |
Reference Brands:- | Femara® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Letrozole (brand name Femara®) is an oral aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. Approved in the US and EU, it comes in a 2.5 mg tablet. Widely available through B2B pharma channels, Letrozole is GMP-compliant and reliably supplied to hospitals and oncology centers at competitive prices
Letrozole, sold under the brand name Femara®, is a highly effective aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Approved in both the US and EU, Letrozole is available in 2.5 mg oral tablets and is widely prescribed for early and advanced-stage breast cancer. As a key hormonal therapy, Letrozole is sourced globally by B2B pharmaceutical wholesalers, hospitals, and oncology clinics. With GMP-compliant manufacturing and reliable supply chains, Letrozole offers consistent quality and competitive pricing in the European and American markets, supporting cancer care with trusted pharmaceutical standards.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications